Wells Fargo & Company Amneal Pharmaceuticals, Inc. Put Options Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding AMRX
# of Institutions
183Shares Held
138MCall Options Held
234KPut Options Held
45.9K-
Ubs Group Ag21.8MShares$188 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA14MShares$120 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$106 Million1.95% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$97.1 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$92.3 Million2.02% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.3B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...